| The 2016 European Thyroid Association/European Group on Graves' orbitopathy guidelines for the management of Graves' orbitopathy L Bartalena, L Baldeschi, K Boboridis, A Eckstein, GJ Kahaly, C Marcocci, ... European thyroid journal 5 (1), 9-26, 2016 | 1000 | 2016 |
| Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO L Bartalena, L Baldeschi, A Dickinson, A Eckstein, P Kendall-Taylor, ... European Journal of Endocrinology 158 (3), 273-285, 2008 | 865 | 2008 |
| Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy L Bartalena, L Baldeschi, AJ Dickinson, A Eckstein, P Kendall-Taylor, ... Thyroid 18 (3), 333-346, 2008 | 596 | 2008 |
| The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy L Bartalena, GJ Kahaly, L Baldeschi, CM Dayan, A Eckstein, C Marcocci, ... European journal of endocrinology 185 (4), G43-G67, 2021 | 572 | 2021 |
| Thyrotropin receptor autoantibodies are independent risk factors for Graves’ ophthalmopathy and help to predict severity and outcome of the disease AK Eckstein, M Plicht, H Lax, M Neuhäuser, K Mann, S Lederbogen, ... The Journal of Clinical Endocrinology & Metabolism 91 (9), 3464-3470, 2006 | 556 | 2006 |
| Teprotumumab for the treatment of active thyroid eye disease RS Douglas, GJ Kahaly, A Patel, S Sile, EHZ Thompson, R Perdok, ... New England Journal of Medicine 382 (4), 341-352, 2020 | 502 | 2020 |
| Mutations in the human retinal degeneration slow (RDS) gene can cause either retinitis pigmentosa or macular dystrophy J Wells, J Wroblewski, J Keen, C Inglehearn, C Jubb, A Eckstein, M Jay, ... Nature genetics 3 (3), 213-218, 1993 | 459 | 1993 |
| Human recombinant interferon alfa-2a for the treatment of Behcet's disease with sight threatening posterior or panuveitis I Kötter, M Zierhut, AK Eckstein, R Vonthein, T Ness, I Günaydin, ... British Journal of Ophthalmology 87 (4), 423-431, 2003 | 352 | 2003 |
| Graves’ disease TF Davies, S Andersen, R Latif, Y Nagayama, G Barbesino, M Brito, ... Nature reviews Disease primers 6 (1), 1-23, 2020 | 283 | 2020 |
| Impact of smoking on the response to treatment of thyroid associated ophthalmopathy A Eckstein, B Quadbeck, G Mueller, AW Rettenmeier, R Hoermann, ... British Journal of Ophthalmology 87 (6), 773-776, 2003 | 275 | 2003 |
| Dry eye syndrome in thyroid‐associated ophthalmo‐pathy: lacrimal expression of TSH receptor suggests involvement of TSHR‐specific autoantibodies AK Eckstein, A Finkenrath, A Heiligenhaus, K Renzing‐Köhler, J Esser, ... Acta Ophthalmologica Scandinavica 82 (3p1), 291-297, 2004 | 197 | 2004 |
| European Group on Graves’ Orbitopathy (EUGOGO). The 2016 European Thyroid Association/European Group on Graves’ Orbitopathy Guidelines for the Management of Graves’ Orbitopathy L Bartalena, L Baldeschi, K Boboridis, A Eckstein, GJ Kahaly, C Marcocci, ... Eur Thyroid J 5 (1), 9-26, 2016 | 183 | 2016 |
| Treatment of ocular symptoms of Behçet’s disease with interferon α2a: a pilot study I Kötter, AK Eckstein, N Stübiger, M Zierhut British journal of ophthalmology 82 (5), 488-494, 1998 | 178 | 1998 |
| Compensatory visual field training for patients with hemianopia after stroke G Nelles, J Esser, A Eckstein, A Tiede, H Gerhard, HC Diener Neuroscience letters 306 (3), 189-192, 2001 | 174 | 2001 |
| Graves’ orbitopathy as a rare disease in Europe: a European Group on Graves’ Orbitopathy (EUGOGO) position statement P Perros, L Hegedüs, L Bartalena, C Marcocci, GJ Kahaly, L Baldeschi, ... Orphanet journal of rare diseases 12, 1-6, 2017 | 168 | 2017 |
| Outcome of orbital decompression for disfiguring proptosis in patients with Graves’ orbitopathy using various surgical procedures MP Mourits, HM Bijl, MA Altea, L Baldeschi, K Boboridis, N Currò, ... British Journal of Ophthalmology 93 (11), 1518-1523, 2009 | 166 | 2009 |
| Euthyroid and primarily hypothyroid patients develop milder and significantly more asymmetrical Graves ophthalmopathy AK Eckstein, C Loesch, D Glowacka, M Schott, K Mann, J Esser, ... British Journal of Ophthalmology 93 (8), 1052-1056, 2009 | 160 | 2009 |
| Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial GJ Kahaly, M Riedl, J König, S Pitz, K Ponto, T Diana, E Kampmann, ... The Lancet Diabetes & Endocrinology 6 (4), 287-298, 2018 | 152 | 2018 |
| Clinical results of anti‐inflammatory therapy in Graves’ ophthalmopathy and association with thyroidal autoantibodies AK Eckstein, M Plicht, H Lax, H Hirche, B Quadbeck, K Mann, KP Steuhl, ... Clinical endocrinology 61 (5), 612-618, 2004 | 134 | 2004 |
| Prevalence of metabolically healthy obese and metabolically obese but normal weight in adults worldwide: a meta-analysis B Wang, R Zhuang, X Luo, L Yin, C Pang, T Feng, H You, Y Zhai, Y Ren, ... Hormone and metabolic research 47 (11), 839-845, 2015 | 127 | 2015 |
